13 22

Cited 0 times in

Cost-Effectiveness Analysis for National Dyslipidemia Screening Program in Korea: Results of Best Case Scenario Analysis Using a Markov Model

DC FieldValueLanguage
dc.contributor.author김태현-
dc.contributor.author남정모-
dc.contributor.author박소희-
dc.contributor.author박은철-
dc.date.accessioned2019-10-28T02:05:53Z-
dc.date.available2019-10-28T02:05:53Z-
dc.date.issued2019-
dc.identifier.issn1225-4266-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/171482-
dc.description.abstractBackground: This study evaluated the cost-effectiveness of 21 different national dyslipidemia screening strategies according to total cholesterol (TC) cutoff and screening interval among 40 years or more for the primary prevention of coronary heart disease over a lifetime in Korea, from a societal perspective. Methods: A decision tree was used to estimate disease detection with the 21 different screening strategies, while a Markov model was used to model disease progression until death, quality-adjusted life years (QALYs) and costs from a Korea societal perspective. Results: The results showed that the strategy with TC 200 mg/dL and 4-year interval cost ₩4,625,446 for 16.65105 QALYs per person and strategy with TC 200 mg/dL and 3-year interval cost ₩4,691,771 for 16.65164 QALYs compared with ₩3,061,371 for 16.59877 QALYs for strategy with no screening. The incremental cost-effectiveness ratio of strategy with TC 200 mg/dL and 4-year interval versus strategy with no screening was ₩29,916,271/QALY. At a Korea willingness-to-pay threshold of ₩30,500,000/QALY, strategy with TC 200 mg/dL and 4-year interval is cost-effective compared with strategy with no screening. Sensitivity analyses showed that results were robust to reasonable variations in model parameters. Conclusion: In this study, revised national dyslipidemia screening strategy with TC 200 mg/dL and 4-year interval could be a cost-effective option. A better understanding of the Korean dyslipidemia population may be necessary to aid in future efforts to improve dyslipidemia diagnosis and management.-
dc.description.statementOfResponsibilityopen-
dc.languageKorean-
dc.publisher한국보건행정학회-
dc.relation.isPartOfKorean Journal of Health Policy and Administration (보건행정학회지)-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.titleCost-Effectiveness Analysis for National Dyslipidemia Screening Program in Korea: Results of Best Case Scenario Analysis Using a Markov Model-
dc.typeArticle-
dc.contributor.collegeGraduate School of Public Health (보건대학원)-
dc.contributor.departmentGraduate School of Public Health (보건대학원)-
dc.contributor.googleauthorJae-Hyun Kim-
dc.contributor.googleauthorEun-Cheol Park-
dc.contributor.googleauthorTae-Hyun Kim-
dc.contributor.googleauthorChung-Mo Nam-
dc.contributor.googleauthorSung-Youn Chun-
dc.contributor.googleauthorTae-Hoon Lee-
dc.contributor.googleauthorSohee Park-
dc.identifier.doi10.4332/KJHPA.2019.29.3.357-
dc.contributor.localIdA01082-
dc.contributor.localIdA01264-
dc.contributor.localIdA01264-
dc.contributor.localIdA01531-
dc.contributor.localIdA01531-
dc.contributor.localIdA01618-
dc.contributor.localIdA01618-
dc.relation.journalcodeJ02025-
dc.identifier.eissn2289-0149-
dc.subject.keywordCost-
dc.subject.keywordDyslipidemia-
dc.subject.keywordEffectiveness-
dc.subject.keywordScreening-
dc.contributor.alternativeNameKim, Tae Hyun-
dc.contributor.affiliatedAuthor김태현-
dc.contributor.affiliatedAuthor남정모-
dc.contributor.affiliatedAuthor남정모-
dc.contributor.affiliatedAuthor박소희-
dc.contributor.affiliatedAuthor박소희-
dc.contributor.affiliatedAuthor박은철-
dc.contributor.affiliatedAuthor박은철-
dc.citation.volume29-
dc.citation.number3-
dc.citation.startPage357-
dc.citation.endPage367-
dc.identifier.bibliographicCitationKorean Journal of Health Policy and Administration (보건행정학회지), Vol.29(3) : 357-367, 2019-
Appears in Collections:
4. Graduate School of Public Health (보건대학원) > Graduate School of Public Health (보건대학원) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Preventive Medicine and Public Health (예방의학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.